Risk of postoperative bleeding and thromboembolic events in anticoagulated patients undergoing transurethral resection of bladder tumors.

ABSTRACT:

Background

Transurethral resection of the bladder (TURB) harbors a high-risk for postoperative bleeding, especially in patients requiring anticoagulation. Recently, direct oral anticoagulants (DOACs) have become a popular alternative to vitamin K antagonists (VKAs), though their impact on TURB complications remains unclear.

Objectives

To assess the postoperative complications of TURB from patients taking DOACs and VKAs.

Design

Retrospective cohort study.

Materials and methods

We retrospectively identified anticoagulated patients undergoing a TURB at our institution between 2012 and 2022 and divided them into two groups: whether they received VKA or DOAC. Follow-up of each patient was performed for 3 months. Occurrence and time to event of postoperative bleeding

SUBMITTER: Scherer TP 

PROVIDER: S-EPMC11792014 | biostudies-literature | 2025 Jan-Dec

REPOSITORIES: biostudies-literature